On September 2, 2020, the Hearing in Teva’s “Post Grant Review” challenging Corcept’s U.S. Patent Number 10,195,214 (which covers Corcept’s Korlym product) was held before the United States Patent & Trademark Office’s (“USPTO”) Patent Trial & Appeal Board (“PTAB”). This was in PGR2019-00048, and we now expect the PTAB to issue its Final Written Decision […]
Our Blog Posts
While the majority of our research is reserved for clients only, Our blog is a great preview of our service. Note that our blog communicates only a small fraction of the amount of situations we follow and provide research on.
- Note that blog posts represent our research as of the time of publishing, MDC makes no guarantee that the information presented will be updated in the future. See our disclosures for additional information.
We are not lawyers, and we do not practice law or render legal advice. MDC Financial Research is a State-Registered Investment Advisor with Financial Analysts that approach legal situations from an investor angle for investment purposes. MDC Financial Research, LLC is currently registered as an Investment Advisor in the States of California, Illinois, and New York. Additional information and disclosures are contained in MDC Financial Research’s Form ADV and Form ADV Part 2 (Brochure).
Copyright © 2026, MDC Financial Research, LLC. All rights reserved.
Contact
MDC Financial Research, LLC
El Dorado Hills, CA
(510) 894-4476
Info@MDCFinancial.com
El Dorado Hills, CA
(510) 894-4476
Info@MDCFinancial.com